0
ARTICLE |

Breast Cancer in Hypothyroid Women Using Thyroid Supplements FREE

Daniel A. Hoffman, PhD; William M. McConahey, MD; Louise A. Brinton, PhD; Joseph F. Fraumeni, Jr, MD
[+] Author Affiliations

Reprint requests to National Cancer Institute, Environmental Epidemiology Branch, 3C16 Landow Bldg, Bethesda, MD 20205 (Dr Hoffman).


JAMA. 1984;251(5):616-619. doi:10.1001/jama.1984.03340290030015
Text Size: A A A
Published online

The risk of breast cancer associated with thyroid supplementation for iatrogenic hypothyroidism was investigated in women treated for hyperthyroidism at the Mayo Clinic, Rochester, Minn. One or more years after the diagnosis of hypothyroidism, there were 47 cases of breast cancer observed among 1,665 women compared with 52.9 cases expected, a ratio of observed to expected cases (standardized incidence ratio [SIR]) of 0.9. There was also no breast cancer excess among women who remained euthyroid (SIR=1.0). Breast cancer risks were not influenced by various factors associated with the management of hyperthyroidism or subsequent hypothyroidism. No increased risk was observed in hypothyroid women categorized by breast cancer risk factors except for women who reported a previous breast biopsy, an excess also observed among euthyroid patients. The results of this study indicate that use of thyroid supplements does not increase the risk of breast cancer developing.

(JAMA 1984;251:616-619)

REFERENCES

Kapdi CC, Wolfe JN:  Breast cancer: Relationship to thyroid supplements for hypothyroidism . JAMA 1976;;236:1124-1127.
Gorman CA, Becker DV, Greenspan FS, et al:  Breast cancer and thyroid therapy: Statement by the American Thyroid Association . JAMA 1977;;237:1459-1460.
Hoffman DA, McConahey WM, Diamond EL, et al:  Mortality in women treated for hyperthyroidism . Am J Epidemiol 1982;;115:243-254.
Hoffman DA, McConahey WM, Fraumeni JF Jr, et al:  Cancer incidence following treatment of hyperthyroidism . Int J Epidemiol 1982;; 11:218-224.
Saenger EL, Thoma GE, Tompkins EA:  Incidence of leukemia following treatment of hyperthyroidism: Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-up Study . JAMA 1968;;205:855-862.
Monson RR:  Analysis of relative survival and proportional mortality . Comput Biomed Res 1974;;7:325-332.
Rothman KJ, Boice JD Jr: Epidemiologic Analysis With a Programmable Calculator, NIH publication 79-1649. Government Printing Office, 1979.
Munoz JM, Gorman CA, Elveback LR, et al:  Incidence of malignant neoplasms of all types in patients with Graves' disease . Arch Intern Med 1978;;138:944-947.
Wallace RB, Sherman BM, Bean JA, et al:  Thyroid hormone use in patients with breast cancer: Absence of an association . JAMA 1978;; 239:958.
Shapiro S, Slone D, Kaufman DW, et al:  Use of thyroid supplements in relation to risk of breast cancer . JAMA 1980;;244:1685-1687.
Danielson DA, Jick H, Hunter JR, et al:  Nonestrogenic drugs and breast cancer . Am J Epidemiol 1982;;116:329-332.
Levy J, Levy JA:  Role of hypometabolic state in cancer . Am Practitioner Digest Treatment 1951;;2:522-526.
Mittra I, Hayward JL:  Hypothalmic-pituitary-thyroid axis in breast cancer . Lancet 1974;; 1:885-888.
Stadel BV:  Dietary iodine and risk of breast, endometrial, and ovarian cancer . Lancet 1976;;1:890-891.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Kapdi CC, Wolfe JN:  Breast cancer: Relationship to thyroid supplements for hypothyroidism . JAMA 1976;;236:1124-1127.
Gorman CA, Becker DV, Greenspan FS, et al:  Breast cancer and thyroid therapy: Statement by the American Thyroid Association . JAMA 1977;;237:1459-1460.
Hoffman DA, McConahey WM, Diamond EL, et al:  Mortality in women treated for hyperthyroidism . Am J Epidemiol 1982;;115:243-254.
Hoffman DA, McConahey WM, Fraumeni JF Jr, et al:  Cancer incidence following treatment of hyperthyroidism . Int J Epidemiol 1982;; 11:218-224.
Saenger EL, Thoma GE, Tompkins EA:  Incidence of leukemia following treatment of hyperthyroidism: Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-up Study . JAMA 1968;;205:855-862.
Monson RR:  Analysis of relative survival and proportional mortality . Comput Biomed Res 1974;;7:325-332.
Rothman KJ, Boice JD Jr: Epidemiologic Analysis With a Programmable Calculator, NIH publication 79-1649. Government Printing Office, 1979.
Munoz JM, Gorman CA, Elveback LR, et al:  Incidence of malignant neoplasms of all types in patients with Graves' disease . Arch Intern Med 1978;;138:944-947.
Wallace RB, Sherman BM, Bean JA, et al:  Thyroid hormone use in patients with breast cancer: Absence of an association . JAMA 1978;; 239:958.
Shapiro S, Slone D, Kaufman DW, et al:  Use of thyroid supplements in relation to risk of breast cancer . JAMA 1980;;244:1685-1687.
Danielson DA, Jick H, Hunter JR, et al:  Nonestrogenic drugs and breast cancer . Am J Epidemiol 1982;;116:329-332.
Levy J, Levy JA:  Role of hypometabolic state in cancer . Am Practitioner Digest Treatment 1951;;2:522-526.
Mittra I, Hayward JL:  Hypothalmic-pituitary-thyroid axis in breast cancer . Lancet 1974;; 1:885-888.
Stadel BV:  Dietary iodine and risk of breast, endometrial, and ovarian cancer . Lancet 1976;;1:890-891.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.